Call Options Transactions Made in Q4 2023 in Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL) during Q4 2023. The information is specifically focused on institutions that hold call options of AbCellera Biologics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
76.7K+ 54.55% |
$300K - $455K
|
217K
$641K
|
|
|
Feb 14, 2024
Q4 2023
|
Hap Trading, LLC
New York, NY |
BUY
|
CALL |
65.2KNew |
$255K - $387K
|
65.2K
$192K
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
CALL |
30.2K+ 3355.56% |
$118K - $179K
|
31.1K
$91.7K
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Trading LLC
Plymouth, MN |
SELL
|
CALL |
-1.7K- 9.77% |
$6.65K - $10.1K
|
15.7K
$46.3K
|
|
|
Feb 14, 2024
Q4 2023
|
Gts Securities LLC
New York, NY |
SELL
|
CALL |
-6.5K- 21.52% |
$25.4K - $38.5K
|
23.7K
$69.9K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-38.7K- 11.06% |
$151K - $229K
|
311K
$918K
|